Back to User profile » Prof. Dr. Matthias Augustin
Papers published by Prof. Dr. Matthias Augustin:
Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE Study
Mrowietz U, Sommer R, Reguiai Z, Gerdes S, Daudén E, Weger W, Maul JT, Naldi L, Ghislain PD, Laws PM, De Jong EMGJ, Mburu S, Koscielny V, Massana E, Sapena V, Domenech A, Kasujee I, Augustin M
Psoriasis: Targets and Therapy 2026, 16:590189
Published Date: 12 May 2026
Prevalence of Genital Psoriasis and Its Impact on Patients’ Sexual Life in Routine Care: Epidemiologic Survey in Germany
Janke TM, Sorbe C, Sommer R, Bickert T, Mrowietz U, Gomis-Kleindienst S, Schild M, Lohmann K, Augustin M
Psoriasis: Targets and Therapy 2026, 16:516803
Published Date: 21 January 2026
Utilization and Costs of Laboratory Monitoring in Biological and Non-Biological Psoriasis Treatment – Large-Scale Claims Data Analysis
Wagner JN, Hagenström K, Müller KS, Stephan B, Augustin M, von Kiedrowski R
Psoriasis: Targets and Therapy 2025, 15:327-338
Published Date: 5 August 2025
Epidemiology and Health Care of Generalized Pustular Psoriasis in Germany – Methodology and Outcomes of Claims Data Analysis
Hagenström K, Müller K, Ben-Anaya N, Augustin M
Psoriasis: Targets and Therapy 2025, 15:273-283
Published Date: 15 July 2025
Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive Study
Mrowietz U, Sommer R, Gerdes S, Reguiai Z, Weger W, Daudén E, Maul JT, Ghislain PD, Laws PM, Naldi L, De Jong E, Mburu S, Koscielny V, Massana E, Domenech A, Gaarn du Jardin K, Kasujee I, Augustin M
Psoriasis: Targets and Therapy 2025, 15:243-259
Published Date: 28 June 2025
Evolution of Drug Supply for Psoriasis from 2010 to 2022 – Real-World Claims Data Analysis in Germany
Hagenström K, Klinger T, Stephan B, Augustin M
Psoriasis: Targets and Therapy 2025, 15:221-231
Published Date: 27 June 2025
Are Systemic Drug Choices for Psoriasis by Dermatologists Compatible with Psoriatic Arthritis? Data from the German National Psoriasis Registry PsoBest
Sorbe C, Kargin S, von Kiedrowski R, Thaci D, Weyergraf A, Blome C, Augustin M, Stephan B
Psoriasis: Targets and Therapy 2025, 15:197-207
Published Date: 30 May 2025
Successful Treatment of Linear Psoriasis With the IL-17a-Antagonist Ixekizumab: A Case Report
Christov S, Ohm F, Augustin M, Wagner JN
Psoriasis: Targets and Therapy 2025, 15:23-28
Published Date: 21 January 2025
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries
Valencia López MJ, Stephan B, Meineke A, Wolf S, Thaci D, Mrowietz U, Andrees V, Rustenbach SJ, Reich K, Thalmann L, Bogena H, Staubach P, von Kiedrowski RM, Augustin M
Psoriasis: Targets and Therapy 2024, 14:29-38
Published Date: 14 May 2024
Learning from the Experiences in the COVID-19 Pandemic – Impact on Quality of Life and Challenges for the Staff of a Dermatological Hospital and Rehabilitation Center in Germany: A Retrospective Analysis
Kuhls LJ, Demiri J, Weidlich A, Weidlich S, Trinkaus J, Steinbrink K, Augustin M, Tsianakas A
Clinical, Cosmetic and Investigational Dermatology 2023, 16:3279-3290
Published Date: 13 November 2023
Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea Treatment
Augustin M, Sommer R, Blome C, Kirsten N, Langenbruch A
Patient Preference and Adherence 2023, 17:1335-1345
Published Date: 1 June 2023
Development and Validation Features of the Patient Benefit Index for the Treatment of Allergic Rhinoconjunctivitis with Allergen Immunotherapy
Langenbruch A, Wüstenberg E, Wolf H, Augustin M
Journal of Asthma and Allergy 2022, 15:611-621
Published Date: 11 May 2022
Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
Hampton P, Borg E, Hansen JB, Augustin M
Psoriasis: Targets and Therapy 2021, 11:123-131
Published Date: 3 November 2021
Population-Based Epidemiologic Study in Venous Diseases in Germany – Prevalence, Comorbidity, and Medical Needs in a Cohort of 19,104 Workers
Kirsten N, Mohr N, Gensel F, Alhumam A, Bruning G, Augustin M
Vascular Health and Risk Management 2021, 17:679-687
Published Date: 29 October 2021
Prevalence and Cutaneous Comorbidity of Acne Vulgaris in the Working Population
Kirsten N, Mohr N, Augustin M
Clinical, Cosmetic and Investigational Dermatology 2021, 14:1393-1400
Published Date: 2 October 2021
Prevalence and Associated Diseases of Seborrheic Skin in Adults
Kirsten N, Mohr N, Alhumam A, Augustin M
Clinical Epidemiology 2021, 13:845-851
Published Date: 18 September 2021
Prevalence and Medications of Atopic Dermatitis in Germany: Claims Data Analysis
Hagenström K, Sauer K, Mohr N, Dettmann M, Glaeske G, Petersen J, Garbe C, Steimle T, Augustin M
Clinical Epidemiology 2021, 13:593-602
Published Date: 22 July 2021
Determining the Minimal Important Difference for the Wound-QoL Questionnaire
Topp J, Blome C, Augustin M, Mohr N, Debus ES, Diener H, Sommer R
Patient Preference and Adherence 2021, 15:1571-1578
Published Date: 14 July 2021
Epidemiology of Vitiligo – A Dual Population-Based Approach
Mohr N, Petersen J, Kirsten N, Augustin M
Clinical Epidemiology 2021, 13:373-382
Published Date: 26 May 2021
Documenting Patient Data in Psoriasis Clinical Practice—Patient Focus Groups Supporting Psoriasis Experts’ Decision-making
Otten M, Augustin M
Patient Preference and Adherence 2021, 15:549-557
Published Date: 8 March 2021
Measuring the importance of health domains in psoriasis – discrete choice experiment versus rating scales
Gutknecht M, Schaarschmidt ML, Danner M, Blome C, Augustin M
Patient Preference and Adherence 2018, 12:363-373
Published Date: 15 March 2018
Efficacy and tolerability of liposomal polyvinylpyrrolidone-iodine hydrogel for the localized treatment of chronic infective, inflammatory, dermatoses: an uncontrolled pilot study
Augustin M, Goepel L, Jacobi A, Bosse B, Mueller S, Hopp M
Clinical, Cosmetic and Investigational Dermatology 2017, 10:373-384
Published Date: 22 September 2017